P‐Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. (25th July 2017)
- Record Type:
- Journal Article
- Title:
- P‐Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. (25th July 2017)
- Main Title:
- P‐Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model
- Authors:
- Neog, Manoj Kumar
Joshua Pragasam, Samuel
Krishnan, Moorthy
Rasool, Mahaboobkhan - Abstract:
- Abstract: This study was designed to explore the underlying mechanism of p ‐coumaric acid (CA), a dietary polyphenol in adjuvant‐induced arthritis (AIA) rat model with reference to synovitis and osteoclastogenesis. Celecoxib (COX‐2 selective inhibitor) (5 mg/kg b.wt) was used as a reference drug. CA remarkably suppressed the paw edema, body weight loss and inflammatory cytokine and chemokine levels (TNF‐α, IL‐1β, IL‐6, and MCP‐1) in serum and ankle joint of arthritic rats. Consistently, CA reduced the expression of osteoclastogenic factors (RANKL and TRAP), pro‐inflammatory cytokines (TNF‐α, IL‐1β, IL‐6, and IL‐17), and inflammatory enzymes (iNOS and COX‐2) in arthritic rats. However, OPG expression was found elevated. Besides, the abundance of transcription factors (NF‐κB‐p65, and p‐NF‐κB‐p65, NFATc‐1, and c‐Fos) and MAP kinases (JNK, p‐JNK, and ERK1/2) expression was alleviated in CA administered arthritic rats. In addition, CA truncated osteoclastogenesis by regulating the RANKL/OPG imbalance in arthritic rats and suppressing the RANKL‐induced NFATc‐1 and c‐Fos expression in vitro . Radiological (CT and DEXA scan) and histological assessments authenticated that CA inhibited TRAP, bone destruction and cartilage degradation in association with enhanced bone mineral density. Taken together, our findings suggest that CA demonstrated promising anti‐arthritic effect and could prove useful as an alternative drug in RA therapeutics. © 2017 BioFactors, 43(5):698–717, 2017
- Is Part Of:
- BioFactors. Volume 43:Number 5(2017:Sep./Oct.)
- Journal:
- BioFactors
- Issue:
- Volume 43:Number 5(2017:Sep./Oct.)
- Issue Display:
- Volume 43, Issue 5 (2017)
- Year:
- 2017
- Volume:
- 43
- Issue:
- 5
- Issue Sort Value:
- 2017-0043-0005-0000
- Page Start:
- 698
- Page End:
- 717
- Publication Date:
- 2017-07-25
- Subjects:
- p‐coumaric acid -- adjuvant‐induced arthritis -- synovitis -- RANKL -- osteoclastogenesis -- osteoproteogrin
Vitamins -- Physiological effect -- Periodicals
Trace elements -- Physiological effect -- Periodicals
Growth factors -- Physiological effect -- Periodicals
Plant growth promoting substances -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Nutritional Physiological Phenomena -- Periodicals
Trace Elements -- metabolism -- Periodicals
Vitamins -- metabolism -- Periodicals
Molecular Biology -- Periodicals
612.399 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1872-8081 ↗
http://search.epnet.com/direct.asp?jid=BFT&db=afh ↗
http://www.ebscohost.com ↗
http://www3.interscience.wiley.com/journal/121452383/ ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0951-6433;screen=info;ECOIP ↗ - DOI:
- 10.1002/biof.1377 ↗
- Languages:
- English
- ISSNs:
- 0951-6433
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2072.123000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5073.xml